NO20081617L - Metoder for fremstilling av Glutaminsyrederivater - Google Patents

Metoder for fremstilling av Glutaminsyrederivater

Info

Publication number
NO20081617L
NO20081617L NO20081617A NO20081617A NO20081617L NO 20081617 L NO20081617 L NO 20081617L NO 20081617 A NO20081617 A NO 20081617A NO 20081617 A NO20081617 A NO 20081617A NO 20081617 L NO20081617 L NO 20081617L
Authority
NO
Norway
Prior art keywords
preparation
glutamic acid
acid derivatives
methods
novel methods
Prior art date
Application number
NO20081617A
Other languages
English (en)
Norwegian (no)
Inventor
Joseph Zeldis
David Michael Blum
Ronald Stanley Michalak
Mel Jennings
Timothy Doyle
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20081617L publication Critical patent/NO20081617L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20081617A 2005-10-13 2008-04-02 Metoder for fremstilling av Glutaminsyrederivater NO20081617L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72644105P 2005-10-13 2005-10-13
PCT/US2006/026892 WO2007044100A1 (fr) 2005-10-13 2006-07-11 Méthodes de synthèse de dérivés d'acide glutamique

Publications (1)

Publication Number Publication Date
NO20081617L true NO20081617L (no) 2008-05-06

Family

ID=37119907

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081617A NO20081617L (no) 2005-10-13 2008-04-02 Metoder for fremstilling av Glutaminsyrederivater

Country Status (18)

Country Link
US (1) US7541485B2 (fr)
EP (1) EP1934171A1 (fr)
JP (1) JP2009511578A (fr)
KR (1) KR20080058436A (fr)
CN (1) CN101282927A (fr)
AR (1) AR057451A1 (fr)
AU (1) AU2006299918A1 (fr)
BR (1) BRPI0617348A2 (fr)
CA (1) CA2624866A1 (fr)
CR (1) CR9885A (fr)
EC (1) ECSP088360A (fr)
GT (1) GT200600305A (fr)
IL (1) IL190729A0 (fr)
NO (1) NO20081617L (fr)
PE (1) PE20070526A1 (fr)
RU (1) RU2008113222A (fr)
TW (1) TW200740729A (fr)
WO (1) WO2007044100A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808715A (en) * 2006-06-02 2008-02-16 Wyeth Corp Methods for preparing glutamic acid derivatives and intermediates thereof
US20100216886A1 (en) * 2006-11-09 2010-08-26 Wyeth Polymorphs of n2-(1,1'-biphenyl-4-ylcarbonyl)-n1-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha-glutamine
US9278874B2 (en) * 2011-09-30 2016-03-08 Kemira Oyj Prevention of starch degradation in pulp, paper or board making processes using zinc ions and an oxidizing biocide
DK3054936T5 (da) 2013-10-10 2024-03-18 Eastern Virginia Medical School 4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer
US10526287B2 (en) 2015-04-23 2020-01-07 Constellation Pharmaceuticals, Inc. LSD1 inhibitors and uses thereof
CN109863137B (zh) 2016-10-26 2022-12-16 星座制药公司 Lsd1抑制剂及其医学用途
WO2022175752A1 (fr) 2021-02-19 2022-08-25 Sudo Biosciences Limited Inhibiteurs de tyk2 et leurs utilisations

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2440649A (en) * 1948-04-27 Quinazoline
GB1108819A (en) 1964-07-31 1968-04-03 Rotta Research Lab Derivatives of 2-acylaminobicarboxylic acids and method for preparing same
DE3332633A1 (de) 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5424334A (en) 1991-12-19 1995-06-13 G. D. Searle & Co. Peptide mimetic compounds useful as platelet aggregation inhibitors
US5648368A (en) * 1992-12-01 1997-07-15 Merck & Co., Inc. Fibrinogen receptor antagonists
JPH06192199A (ja) 1992-12-25 1994-07-12 Mitsubishi Kasei Corp ケトン誘導体
US5563127A (en) 1993-03-24 1996-10-08 The Dupont Merck Pharmaceutical Company Boronic acid and ester inhibitors of thrombin
CA2183428A1 (fr) 1994-03-11 1995-09-14 John J. Baldwin Derives de sulfonamide et leur utilisation
GB2292149A (en) 1994-08-09 1996-02-14 Ferring Res Ltd Peptide inhibitors of pro-interleukin-1beta converting enzyme
US6306840B1 (en) 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
JP3353301B2 (ja) 1995-07-24 2002-12-03 藤沢薬品工業株式会社 Ｐｌａ▲下２▼阻害剤としてのエステル類およびアミド類
EP0910564B1 (fr) 1995-11-28 2007-10-31 Cephalon, Inc. Inhibiteurs de cysteine et serine proteases derives d'acides amine d
DE69833858T2 (de) 1997-07-08 2007-02-22 Ono Pharmaceutical Co. Ltd. Aminosäurederivate
JP4129069B2 (ja) 1997-09-16 2008-07-30 株式会社Ａｄｅｋａ アシル化ペプチド類の製造方法
JP4090541B2 (ja) 1997-10-15 2008-05-28 株式会社Ａｄｅｋａ アシル化ペプチド類の製造方法
AU3366899A (en) 1998-03-27 1999-10-18 Regents Of The University Of California, The Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
TWI245035B (en) 1998-06-26 2005-12-11 Ono Pharmaceutical Co Amino acid derivatives and a pharmaceutical composition comprising the derivatives
US6242422B1 (en) 1998-10-22 2001-06-05 Idun Pharmacueticals, Inc. (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
US7157430B2 (en) * 1998-10-22 2007-01-02 Idun Pharmaceuticals, Inc. (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases
DE19851184A1 (de) 1998-11-06 2000-05-11 Aventis Pharma Gmbh N-Arylsulfonyl-aminosäure-omega-amide
US6265610B1 (en) * 1999-01-12 2001-07-24 The University Of North Carolina At Chapel Hill Contrast media for angiography
US6723711B2 (en) * 1999-05-07 2004-04-20 Texas Biotechnology Corporation Propanoic acid derivatives that inhibit the binding of integrins to their receptors
KR100767199B1 (ko) 1999-05-07 2007-10-17 엔싸이시브 파마슈티칼즈 인코퍼레이티드 인테그린이 이의 수용체에 결합하는 것을 억제하는프로판산 유도체
US6493791B1 (en) * 1999-12-20 2002-12-10 Intel Corporation Prioritized content addressable memory
CA2377629A1 (fr) 2000-04-25 2001-11-08 Hae-Young Bae Derives d'acide diphenylbutyrique inhibiteurs de metalloproteinase matricielle
WO2001090077A1 (fr) 2000-05-19 2001-11-29 Guilford Pharmaceuticals, Inc. Derives de sulfonamide et de carbamide de 6(5h) phenanthridinones et utilisations de ceux-ci
CA2321348A1 (fr) * 2000-09-27 2002-03-27 Blaise Magloire N'zemba Derives aromatiques ayant des proprietes inhibant l'integrase de l'hiv
JP2002145849A (ja) 2000-11-10 2002-05-22 Kyorin Pharmaceut Co Ltd アルキニルアミノ酸誘導体及びその製造法
US20050049242A1 (en) * 2000-12-21 2005-03-03 W. Edward Robinson Novel HIV integrase inhibitors and HIV therapy based on drug combinations including integrase inhibitors
US20040009956A1 (en) * 2002-04-29 2004-01-15 Dehua Pei Inhibition of protein tyrosine phosphatases and SH2 domains by a neutral phosphotyrosine mimetic
AU2004266233A1 (en) 2003-08-13 2005-03-03 Amgen, Inc. Melanin concentrating hormone receptor antagonist
WO2005040355A2 (fr) 2003-10-24 2005-05-06 Exelixis, Inc. Modulateurs de kinases tao et leurs methodes d'utilisation
AU2003304638A1 (en) 2003-12-04 2005-07-14 Wyeth Biaryl sulfonamides and methods for using same
KR20060109937A (ko) 2003-12-15 2006-10-23 니뽄 다바코 산교 가부시키가이샤 Ｎ-치환-ｎ-술포닐아미노시클로프로판 화합물 및 그의약제학적 용도
WO2005087215A1 (fr) 2004-03-09 2005-09-22 Elan Pharmaceuticals, Inc. Uree et carbamate substitues, phenacyl-2-hydroxy-3-diaminoalcane, et benzamide-2-hydroxy-3-diaminoalcane inhibiteurs d'aspartyl-protease
EP1902014A2 (fr) * 2005-07-11 2008-03-26 Wyeth Inhibiteurs de glutamate aggrecanase
DE102006018250A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Verfahren zum Herstellen von cyclischen Depsipeptiden
TW200808715A (en) * 2006-06-02 2008-02-16 Wyeth Corp Methods for preparing glutamic acid derivatives and intermediates thereof

Also Published As

Publication number Publication date
WO2007044100A1 (fr) 2007-04-19
PE20070526A1 (es) 2007-06-11
CR9885A (es) 2008-06-16
EP1934171A1 (fr) 2008-06-25
AR057451A1 (es) 2007-12-05
CN101282927A (zh) 2008-10-08
AU2006299918A1 (en) 2007-04-19
US20070088172A1 (en) 2007-04-19
BRPI0617348A2 (pt) 2011-07-26
JP2009511578A (ja) 2009-03-19
ECSP088360A (es) 2008-05-30
KR20080058436A (ko) 2008-06-25
IL190729A0 (en) 2008-11-03
TW200740729A (en) 2007-11-01
RU2008113222A (ru) 2009-11-20
GT200600305A (es) 2007-02-26
US7541485B2 (en) 2009-06-02
CA2624866A1 (fr) 2007-04-19

Similar Documents

Publication Publication Date Title
CY1112402T1 (el) Ενισχυτες υποδοχεων γλουταμικου
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
WO2006092213A8 (fr) Pyrazolylcarboxanilides
NO20074093L (no) Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
NO20073678L (no) Nye fremgangsmater for fremstilling av benzofuran
EA200800321A1 (ru) Ингибиторы гистондеацетилазы
ATE362932T1 (de) Azaindolverbindungen als kinaseinhibitoren
SE0301373D0 (sv) Novel compounds
ATE411994T1 (de) Herstellung eines substituierten chinoxalins von hoher reinheit
NO20081617L (no) Metoder for fremstilling av Glutaminsyrederivater
EA201070804A1 (ru) (аза)индольное производное, замещенное по положению 5, содержащая его фармацевтическая композиция, промежуточные соединения и способ их получения
NO20081621L (no) Tetrahydrokinoliner, syntese og intermediater
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
NO20080468L (no) Diazepinokinoliner, synteser av disse samt intermediater
DK1831239T3 (da) Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-lambda-lacton og nøgle-mellemprodukter til denne fremgangsmåde
ES2333026T3 (es) Derivados de ciclohexil-1,4-diamina sustituidos.
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
WO2009001203A3 (fr) Procédé perfectionné pour la préparation d'aprépitant
EA200801549A1 (ru) Новые производные фенантридина в качестве антагонистов брадикинина
DK1877370T3 (da) Fremgangsmåde til fremstilling af hydrazon-derivater
NO20084839L (no) Metoder for fremstilling av glutaminsyrederivater og melomprodukter
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов
MX2008000011A (es) Procesos para preparar derivados de pirazol-o-glucosido y nuevos intermediarios de dichos procesos.
WO2007054970A3 (fr) Nouvelles formes polymorphes de (s)-(-)-2-amino-6-(n- propylamino) 4,5,6,7- tetrahydrobenzothiazole

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application